Source: Breathe 2006; 2: 295-296



Rating:

Share or cite this content

Citations should be made in the following way:
ELF patient factsheet - The normal lung. Breathe 2006; 2: 295-296

Member's Comments

No comment yet.

Related content which might interest you: The patient behind the lung Source: Annual Congress 2007 - Primary care: from the patient to the politics Year: 2007 Osteopontin levels in sputum supernatant and serum of patients with lung cancer: Does coexistent COPD make the difference? Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 LSC - 2021 - A comprehensive guide to pulmonary mesenchymal populations in the healthy and IPF lung. Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair Year: 2021 Lung ultrasound in children with interstitial lung disease: a pilot study. Source: Virtual Congress 2020 – Tip the hat to paediatric bronchology Year: 2020 Static lung compliance (Cst) and diffusion lung capacity (DLCO) as markers of lung function impairment in sarcoid patients with normal lung volumes Source: Eur Respir J 2003; 22: Suppl. 45, 278s Year: 2003 Lung compliance in patients with pulmonary fibrosis with normal lung volumes Source: Eur Respir J 2007; 30: Suppl. 51, 577s Year: 2007 Time as the fourth dimension of radiology: a patient with diffuse lung disease (interstitial lung disease) Source: International Congress 2016 – GR2 Radiology Year: 2016 Increased expression of a proliferation-inducing ligand (APRIL) in lung leukocytes and alveolar epithelial cells in COPD patients with non small cell lung cancer: A possible link between COPD and lung cancer? Source: International Congress 2016 – Mechanisms of disease Year: 2016 Yearly progression of low lung attenuation area in low dose CT scan for aymptomatic current smokers with normal lung function or GOLD stage I COPD Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013 Whole lung lavage therapy (WLL) of pulmonary alveolar proteinosis (PAP): A global survey of current practices and procedures Source: International Congress 2016 – Orphan diseases I Year: 2016 Assessment of fibrosis in lung biopsies from the European childhood interstitial lung disease (chILD) registry Source: Virtual Congress 2020 – Possible scenarios in the challenging future of rare diffuse parenchymal lung diseases Year: 2020 Dignosing Interstitial lung disease. The value of BAL and (cryo)biopsy Source: ERS Skills Course 2018 Year: 2018 Paradoxically normal lung volume assessed by CXR and total lung capacity in patients with diffuse pulmondary fibrosis and additional emphysema Source: Eur Respir J 2006; 28: Suppl. 50, 98s Year: 2006 Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009 Analysis of breathing acoustic parameters in patients with COPD, interstitial lung diseases and normal subjects Source: Annual Congress 2006 - Assessing the lungs in obstruction: technological advances in lung function testing Year: 2006 Alvolar lymphocytes (AL) in patients with non-small cell lung cancer (NSCLC). Data from tumor-affected lobe Source: International Congress 2015 – Connective tissue disorders Year: 2015 Influence of smoking habit on static lung compliance (Cst) in interstitial lung diseases (ILD) patients Source: Eur Respir J 2002; 20: Suppl. 38, 194s Year: 2002 Ability of the lung clearance index to monitor progression of early lung disease in children with cystic fibrosis Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016 Stereotactic body radiation does not impair respiratory health in patients with stage I non-small cell lung cancer Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013